Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
Lau J, Scott MM, Everett K, Gomes T, Tanuseputro P, Jennings S, Bagnarol R, Zimmermann C, Isenberg SR. CMAJ. 2024;
Low nirmatrelvir/ritonavir use among patients with rheumatoid arthritis: a signal of concern
Individuals with rheumatoid arthritis (RA) may be at increased risk of severe coronavirus disease 2019 (COVID-19) outcomes. Nirmatrelvir/ritonavir has been shown to reduce the risk for hospitalization and death among patients with COVID-19 at risk for progression to severe disease.
Information
Citation
Kwok TSH, Kuriya B, Eder L, Aghanya V, Gatley JM, Widdifield J. J Rheumatol. 2023; Oct 1 [Epub ahead of print].